Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2009050530PMID 20056746PMCID PMC2831862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA expression profiles predictive of human renal allograft status

  2009cited by this paper
• MicroRNAs in Cancer.

  2009cited by this paper
• Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer.

  2009cited by this paper
• The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2*

  2008cited by this paper
• MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis.

  2008cited by this paper
• SMAD proteins control DROSHA-mediated microRNA maturation

  2008cited by this paper
• The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

  2008cited by this paper
• Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis.

  2008cited by this paper
• Differential Regulation of Epithelial and Mesenchymal Markers by δEF1 Proteins in Epithelial–Mesenchymal Transition Induced by TGF-β

  2007cited by this paper
• Solid type clear cell carcinoma of the pancreas: differential diagnosis of an unusual case and review of the literature

  2007cited by this paper
• High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

  2007cited by this paper
• Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta.

  2007cited by this paper
• MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors

  2007cited by this paper
• TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members.

  2007cited by this paper
• A MicroRNA Signature of Hypoxia

  2006cited by this paper
• Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition

  2006cited by this paper
• Regulation of vimentin by SIP1 in human epithelial breast tumor cells

  2006cited by this paper
• Renal fibrosis: new insights into the pathogenesis and therapeutics.

  2006cited by this paper
• Real-time quantification of microRNAs by stem–loop RT–PCR

  2005cited by this paper
• An optimized isolation and labeling platform for accurate microRNA expression profiling.

  2005cited by this paper
• RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.

  2005cited by this paper
• Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.

  2004cited by this paper
• Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs.

  2004cited by this paper
• Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor.

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.

  2001cited by this paper
• Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor β-induced Smad-dependent Transcriptional Activation*

  1999cited by this paper
• Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis.

  1994cited by this paper
• Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

  1993cited by this paper
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

  1992cited by this paper
• Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

  1990cited by this paper
• Effects of cyclosporin A on the development of immune-mediated interstitial nephritis.

  1988cited by this paper

• Salvia miltiorrhiza (Danshen) and its extracts in the alternative treatment of diabetic nephropathy: mechanisms and clinical perspectives.

  2026cites this paper
• A systematic review and meta-analysis of microRNAs in the diagnosis of early diabetic kidney disease

  2025cites this paper
• The HIF-1α/miR-145b/Angpt2 axis attenuates renal fibrosis induced by unilateral renal ischemia–reperfusion

  2025cites this paper
• Serum miR-21 and miR-192 levels in type 2 diabetes: Association with albuminuria and renal function

  2025cites this paper
• Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy

  2024cites this paper
• MiR-192–5p targets cell cycle regulation in diabetic kidney disease via cyclin-dependent kinase inhibitor 3

  2024cites this paper
• microRNAs in kidney diseases: Regulation, therapeutics, and biomarker potential.

  2024cites this paper
• Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action

  2023cites this paper
• The Functional Role of microRNAs and mRNAs in Diabetic Kidney Disease: A Review.

  2023cites this paper
• MicroRNAs Associated with Chronic Kidney Disease in the General Population and High-Risk Subgroups—A Systematic Review

  2023cites this paper
• Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics

  2023influential citation
• Capturing the Kidney Transcriptome by Urinary Extracellular Vesicles—From Pre-Analytical Obstacles to Biomarker Research

  2023cites this paper
• Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation.

  2023cites this paper
• TGF-β1/SMAD在糖尿病肾病中的作用机制与研究进展

  2023cites this paper
• The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease

  2023cites this paper
• Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia

  2022cites this paper
• Modulation of miR-192/NF-κB/ TGF-β/ E-cadherin by thymoquinone protects against diethylnitrosamine /carbon tetrachloride hepatotoxicity.

  2022cites this paper
• On the Relationship between Diabetes and Obstructive Sleep Apnea: Evolution and Epigenetics

  2022cites this paper
• miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms

  2022cites this paper
• Monitoring of Soluble Forms of BAFF System (BAFF, APRIL, sR-BAFF, sTACI and sBCMA) in Kidney Transplantation

  2022cites this paper
• Lipid-Based Nanocarriers in Renal RNA Therapy

  2022cites this paper
• Micro-ribonucleic acid modulation with oxidative stress and inflammation in patients with type 2 diabetes mellitus – a review article

  2022cites this paper
• Epigenetic modification regulates tumor progression and metastasis through EMT (Review)

  2022cites this paper
• Interaction of circulating TGFβ regulatory miRNAs in different severity of diabetic kidney disease

  2022cites this paper
• Natural coumarins: Preclinical evidence-based potential candidates to alleviate diabetic nephropathy

  2022cites this paper
• The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis

  2022influential citation
• Integrated analysis of miRNA and mRNA expression profiles in diabetic mouse kidney treated to Korean Red Ginseng

  2022cites this paper
• miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy

  2022cites this paper
• OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction

  2021cites this paper
• Detection of urinary microRNA biomarkers using diazo sulfonamide-modified screen printed carbon electrodes

  2021cites this paper
• Study of MicroRNA192 as an Early Marker of Nephropathy in Type 2 Diabetic Patients

  2021cites this paper
• Role of microRNAs in Obesity-Related Kidney Disease

  2021cites this paper
• MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of NLRP3 inflammasome.

  2021cites this paper
• Epigenetics in kidney diseases.

  2021cites this paper
• Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease

  2021cites this paper
• Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis

  2021cites this paper
• Intratumoral Fibrosis in Facilitating Renal Cancer Aggressiveness: Underlying Mechanisms and Promising Targets

  2021cites this paper
• TGF-Beta as a Master Regulator of Diabetic Nephropathy

  2021cites this paper
• Epigenetics and Inflammation in Diabetic Nephropathy

  2021cites this paper
• miR-141 mediates recovery from acute kidney injury

  2021cites this paper
• Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease

  2021cites this paper
• The role of epigenetic mechanisms in the pathogenesis of diabetic nephropathy

  2021cites this paper
• AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy.

  2020cites this paper
• Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.

  2020cites this paper
• Inhibition of miR-17~92 Cluster Ameliorates High Glucose-Induced Podocyte Damage

  2020cites this paper
• Diabetic fibrosis.

  2020cites this paper
• Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy

  2020cites this paper
• Interactions Among Non-Coding RNAs in Diabetic Nephropathy

  2020cites this paper
• Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs

  2020cites this paper
• miR-192-5p suppresses uterine receptivity formation through impeding epithelial transformation during embryo implantation.

  2020cites this paper
• Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients.

  2020cites this paper
• Emerging role of miRNAs in renal fibrosis

  2020influential citation
• Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway.

  2020cites this paper
• Simultaneous Assessment of MicroRNA 126 and 192 in Diabetic Nephropathy Patients and Their Relation with Urinary Albumin.

  2020cites this paper
• Plasma microRNA-192 expression as a potential biomarker of diabetic kidney disease in patients with type 2 diabetes mellitus

  2020cites this paper
• MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment.

  2020cites this paper
• Diabetes Microvascular Complications: An Overview of Epigenetic Modifications

  2020cites this paper
• Regulation of aquaporin-2 by RNA interference.

  2020cites this paper
• MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application

  2020influential citation
• ORIGINAL ARTICLE

  2020cites this paper
• Role of identified noncoding RNA in erectile dysfunction

  2020cites this paper
• Tiny Non-coding RNAs in Body Fluids, Possible Biomarkers for Autosomal Dominant Polycystic Kidney Disease.

  2019cites this paper
• Multi omics analysis of fibrotic kidneys in two mouse models

  2019cites this paper
• MicroRNA-488 regulates diabetic nephropathy via TGF-β1 pathway.

  2019cites this paper
• Elevated levels of plasma microRNA-192 in patients with lupus nephritis

  2019cites this paper
• Non-coding RNAs in kidney injury and repair.

  2019cites this paper
• Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis

  2019cites this paper
• circLRP6 regulates high glucose‐induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells

  2019influential citation
• Bariatric Surgery Modulates Urinary Levels of MicroRNAs Involved in the Regulation of Renal Function

  2019influential citation
• Evaluation of microRNA-192 in patients with diabetic nephropathy

  2019cites this paper
• MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients

  2019influential citation
• CD226 deficiency on regulatory T cells aggravates renal fibrosis via up‐regulation of Th2 cytokines through miR‐340

  2019cites this paper
• LncRNA TUG1 ameliorates diabetic nephropathy by inhibiting miR-21 to promote TIMP3-expression.

  2019cites this paper
• Increased Extracellular Matrix Protein Production in Chronic Diabetic Complications: Implications of Non-Coding RNAs

  2019influential citation
• Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy

  2019cites this paper
• Expression of miRNAs-122, -192 and -499 in end stage renal disease associated with acute myocardial infarction

  2019cites this paper
• Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

  2019cites this paper
• MiR‐802 causes nephropathy by suppressing NF‐κB‐repressing factor in obese mice and human

  2019cites this paper
• Expression of exosomal miR-21 and miR-29 in serum of children and adolescents with T1DM and persistent microalbuminuria

  2019cites this paper
• Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy

  2019cites this paper
• Micro RNA-192 Is Negatively Associated With Cardiovascular Events Among Wait-Listed Potential Kidney Transplant Recipients on Hemodialysis Over a 5-year Follow-up Period.

  2019cites this paper
• A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.

  2019cites this paper
• Key Genes Involved in Diabetic Nephropathy Investigated by Microarray Analysis

  2019cites this paper
• microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney

  2019cites this paper
• MicroRNA: a novel biomarker and therapeutic target to combat autophagy in diabetic nephropathy.

  2019cites this paper
• MiR-192-5p in the Kidney Protects Against the Development of Hypertension

  2019cites this paper
• Plasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis

  2018cites this paper
• Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes

  2018cites this paper
• Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation

  2018cites this paper
• Role of MicroRNAs in Renal Parenchymal Diseases—A New Dimension

  2018influential citation
• Biogenesis, Stabilization, and Transport of microRNAs in Kidney Health and Disease

  2018cites this paper
• Impact of miR‐192 and miR‐194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease

  2018cites this paper
• Therapeutic Implication of miRNA in Human Disease

  2018cites this paper
• Genomic approaches in the search for molecular biomarkers in chronic kidney disease

  2018cites this paper
• Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease

  2018cites this paper
• Epigenetic Regulation of Myofibroblast Phenotypes in Fibrosis

  2018cites this paper
• Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies

  2018cites this paper
• Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.

  2018cites this paper
• The regulatory role of microRNAs in angiogenesis‐related diseases

  2018cites this paper
• Renal tubule injury: a driving force toward chronic kidney disease.

  2018cites this paper